Dose-Adjusted EPOCH-Rituximab Combined With Fludarabine Provides an Effective Bridge to Reduced-Intensity Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Lymphoid Malignancies

PURPOSE: There is currently no standard chemotherapy regimen for patients with lymphoid malignancies being considered for reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation (RIC-alloHSCT). The ideal regimen would provide disease control and result in lymphocyte depleti...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Salit, Rachel B., Fowler, Daniel H., Wilson, Wyndham H., Dean, Robert M., Pavletic, Steven Z., Dunleavy, Kieron, Hakim, Frances, Fry, Terry J., Steinberg, Seth M., Hughes, Thomas E., Odom, Jeanne, Bryant, Kelly, Gress, Ronald E., Bishop, Michael R.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Clinical Oncology 2012
Предметы:
Original Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3295571/
https://ncbi.nlm.nih.gov/pubmed/22312100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.37.0296
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы